Peter E. Lipsky
Impact in
- Immunology top 0.01%
- T-cell and B-cell Immunology
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- Immune Response and Inflammation
- Rheumatology top 0.01%
- Systemic Lupus Erythematosus Research
- Rheumatoid Arthritis Research and Therapies
Papers in
- Immunology 363
- T-cell and B-cell Immunology 231
- Immune Cell Function and Interaction 150
- Immunotherapy and Immune Responses 113
- Immune Response and Inflammation 49
- Rheumatology 185
- Systemic Lupus Erythematosus Research 137
- Rheumatoid Arthritis Research and Therapies 51
- Co-authors
- Thomas Dörner (57 shared papers)Amrie C. Grammer (76 shared papers)Laurie S. Davis (38 shared papers)T D Geppert (24 shared papers)Gabor G. Illei (16 shared papers)Lee S. Simon (9 shared papers)Ravinder N. Maini (12 shared papers)Daniel E. Fürst (6 shared papers)
- Journals
- The Journal of Immunology (136 papers)Annals of the Rheumatic Diseases (28 papers)Arthritis Research & Therapy (27 papers)Journal of Clinical Investigation (26 papers)Cellular Immunology (13 papers)
- Partner nations
- United StatesGermanyNetherlands
In The Last Decade
Peter E. Lipsky
669 papers receiving 46.4k citations
Peter E. Lipsky's Hit Papers
Peers
Comparison fields: 5 of 176
- Immunology 21.3k
- Rheumatology 12.7k
- Immunology and Allergy 2.5k
- Hematology 3.5k
- Radiology, Nuclear Medicine and Imaging 6.0k
Countries citing papers authored by Peter E. Lipsky
This map shows the geographic impact of Peter E. Lipsky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter E. Lipsky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter E. Lipsky more than expected).
Fields of papers citing papers by Peter E. Lipsky
This network shows the impact of papers produced by Peter E. Lipsky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter E. Lipsky. The network helps show where Peter E. Lipsky may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter E. Lipsky, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 684 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Infliximab and Methotrexate in the Treatment of Rheumatoid Arthritis Hit paper breakdown → | 2000 | 2540 |
| 2 | Cyclooxygenase in biology and disease Hit paper breakdown → | 1998 | 2210 |
| 3 | Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial Hit paper breakdown → | 1999 | 1950 |
| 4 | Modulatory Effects of 1,25-Dihydroxyvitamin D3 on Human B Cell Differentiation Hit paper breakdown → | 2007 | 937 |
| 5 | Anti-inflammatory and Upper Gastrointestinal Effects of Celecoxib in Rheumatoid Arthritis Hit paper breakdown → | 1999 | 660 |
| 6 | TNF downmodulates the function of human CD4+CD25hi T-regulatory cells Hit paper breakdown → | 2006 | 657 |
| 7 | Regulation of B Cell Differentiation and Plasma Cell Generation by IL-21, a Novel Inducer of Blimp-1 and Bcl-6 Hit paper breakdown → | 2004 | 549 |
| 8 | Cytokines and autoimmunity Hit paper breakdown → | 2002 | 545 |
| 9 | IL-21 Induces Differentiation of Human Naive and Memory B Cells into Antibody-Secreting Plasma Cells Hit paper breakdown → | 2005 | 538 |
| 10 | Systemic lupus erythematosus: an autoimmune disease of B cell hyperactivity Hit paper breakdown → | 2001 | 522 |
| 11 | Disturbed Peripheral B Lymphocyte Homeostasis in Systemic Lupus Erythematosus Hit paper breakdown → | 2000 | 520 |
| 12 | Deficient CD4+CD25high T Regulatory Cell Function in Patients with Active Systemic Lupus Erythematosus Hit paper breakdown → | 2007 | 508 |
| 13 | 2005 | 456 | |
| 14 | 2004 | 446 | |
| 15 | 1998 | 418 | |
| 16 | Tocilizumab in systemic lupus erythematosus: Data on safety, preliminary efficacy, and impact on circulating plasma cells from an open‐label phase I dosage‐escalation study Hit paper breakdown → | 2010 | 412 |
| 17 | Efficacy and Tolerability of Pegloticase for the Treatment of Chronic Gout in Patients Refractory to Conventional Treatment Hit paper breakdown → | 2011 | 396 |
| 18 | 1995 | 392 | |
| 19 | 2000 | 388 | |
| 20 | 2007 | 368 |
About Peter E. Lipsky
Peter E. Lipsky is a scholar working on Immunology, Rheumatology, Radiology, Nuclear Medicine and Imaging, Molecular Biology and Oncology, having authored 684 papers that have together received 48.9k indexed citations. Recurring topics across this work include T-cell and B-cell Immunology (231 papers), Immune Cell Function and Interaction (150 papers), Systemic Lupus Erythematosus Research (137 papers), Monoclonal and Polyclonal Antibodies Research (124 papers), Immunotherapy and Immune Responses (113 papers), Rheumatoid Arthritis Research and Therapies (51 papers), Immune Response and Inflammation (49 papers) and Cell Adhesion Molecules Research (45 papers). The work is most often cited by research in Immunology (21.3k citations), Rheumatology (12.7k citations), Immunology and Allergy (2.5k citations), Hematology (3.5k citations) and Radiology, Nuclear Medicine and Imaging (6.0k citations). Peter E. Lipsky has collaborated with scholars based in United States, Germany and Netherlands. Frequent co-authors include Thomas Dörner, Amrie C. Grammer, Laurie S. Davis, T D Geppert, Gabor G. Illei, Lee S. Simon, Ravinder N. Maini, Daniel E. Fürst, Diane F. Jelinek and E. William St. Clair. Their work appears in journals such as The Journal of Immunology, Annals of the Rheumatic Diseases, Arthritis Research & Therapy, Journal of Clinical Investigation and Cellular Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.